Indivior PLC (NASDAQ:INDV – Get Free Report) shares gapped up prior to trading on Friday . The stock had previously closed at $22.25, but opened at $22.78. Indivior shares last traded at $22.85, with a volume of 1,011 shares trading hands. Analysts Set New Price Targets Separately, Northland Securities began coverage on Indivior in a […]
Addiction treatment specialist Indivior announced on Monday that its US subsidiary has entered into an agreement to settle the claims initiated by the end payor class in the ongoing multi-district suboxone antitrust litigation.
Indivior has agreed to pay $30 million to settle a class action lawsuit filed in a U.S. court by health plans accusing the drugmaker of illegally suppressing generic competition for its opioid addiction treatment Suboxone. The settlement, disclosed on Saturday in a filing by lawyers for the health plans in federal court in Philadelphia, must still be approved by a judge. Indivior is still facing claims by drug wholesalers that bought Suboxone from the Virginia-based company directly, with a trial scheduled in October.
Indivior PLC (NASDAQ:INDV – Get Free Report) shares saw strong trading volume on Thursday . 33,661 shares traded hands during trading, an increase of 266% from the previous session’s volume of 9,186 shares.The stock last traded at $22.67 and had previously closed at $22.63. Analysts Set New Price Targets Separately, Northland Securities assumed coverage on […]